Incorporating Relevant and Meaningful Patient-Reported Outcomes in RCC Clinical Trials
Bellinda King-Kallimanis, PhD of U.S. Food and Drug Administration, Maryland (FDA ) discusses Incorporating Relevant and Meaningful Patient-Reported Outcomes in RCC Clinical Trials at the Seventeen...
Author: kidneycancer
Added: 11/08/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts